For patients interested in next-generation GLP-1 medications: Retatrutide and mazdutide represent the next wave of weight loss peptides, though they are not yet widely available through telehealth platforms
(9738086) May check a level 2 hours after the loading dose, to ensure an adequate level
Vital status was available for 99.9% and 99.8% of patients randomized to insulin glargine and standard care respectively at end of study
Moreover, newer GLP-1 RAs and the long half-life of dual agonists (up to 7 days for Semaglutide) give rise to longer preoperative fasting period requirements and concerns of perioperative management of patients, even in case of treatment interruption [15,16,17]
compounded cost comparison Brand-name semaglutide (Wegovy) costs approximately $1,000 to $1,350 per month without insurance
Rare congenital or genetic encephalopathies (less likely)